Skip to main content
. Author manuscript; available in PMC: 2012 Nov 8.
Published in final edited form as: Eur J Gastroenterol Hepatol. 2011 May;23(5):382–388. doi: 10.1097/MEG.0b013e328345c8c7

Fig. 2.

Fig. 2

Plasma concentrations of glycocholate, taurocholate, and taurochenodeoxycholate in patients with biopsy-proven nonalcoholic steatohepatitis (NASH; n = 36), were significantly higher than that in healthy controls (n = 38). *P < 0.01 for each of the bile acids between NASH and controls.